Clinical trial Recruiting at 1 site Interventional Ages 18 to 120

See if a new tomosynthesis imaging tool helps diagnose MSK issues in ED and clinic

Official title: Evaluation of the Diagnostic Potential of Nanox.ARC Tomosynthesis System for Different Diseases

Run by Nano-X Imaging · NCT07900412 · Data updated 2026-11-12

This study tests whether the Nanox.ARC Digital Tomosynthesis system can add diagnostic value for adults with suspected MSK problems and potentially reduce the need for CT or MRI.

Quick facts

Study typeInterventional
Ages18 Years to 120 Years
SexAll
Enrollment100 (estimated)
SponsorNano-X Imaging
Industry-sponsored
Drugs / interventionsradiation
Locations1 site (Kfar Saba)
StatusRecruiting
StartedOctober 20, 2026
Main results expectedJuly 1, 2027
Study endsAugust 1, 2027
Registry record updatedOctober 28, 2026
Trial IDNCT07900412 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with suspected or confirmed MSK pathology who have recently had plain radiography and are referred for or have undergone CT/MRI within the past 7 days.

Probably not a fit

Patients for whom DTS does not add diagnostic information or who require immediate CT/MRI for urgent management may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-arm study evaluating the diagnostic performance of the Nanox.ARC Digital Tomosynthesis system in adults with suspected or confirmed musculoskeletal pathology presenting to the emergency department or orthopedic clinics. Participants undergo a DTS scan in addition to standard radiography, with the goal of seeing if DTS provides additional clinically relevant information and could lower the future need for CT or MRI. The system is FDA-cleared and CE-marked as an adjunct to radiography, and the study will be conducted in real-world clinical settings at Meir Medical Center, Israel. Outcomes focus on incremental diagnostic information and potential reductions in radiation exposure and healthcare costs. Eligible participants are adults who have had a plain radiograph within 7 days and are undergoing or scheduled for further imaging.

Why it matters

Potential benefit: If successful, DTS could improve diagnostic clarity for MSK conditions and reduce the need for higher-dose imaging like CT or MRI.

How similar studies have gone: Prior studies of digital tomosynthesis in MSK imaging have shown potential diagnostic advantages in certain settings, but this approach remains exploratory in this specific context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female patients aged 18 years or older.
2. Ability and willingness to read, understand, and sign the Informed Consent Form (ICF).
3. Clinical status: has undergone a conventional radiograph with or without advanced imaging (CT/MRI) within the past 7 days for a suspected or confirmed MSK pathology; OR is referred to undergo advanced imaging (CT/MRI) or an additional radiograph within the same 7-day timeframe, in the presence of an available radiograph.
4. Negative pregnancy test (for women under the age of 50).

Exclusion Criteria:

1. Cases in which a delay caused by participation in the study could negatively impact the patient's clinical condition or pose a risk to their health or life.
2. Pregnant or breastfeeding women.
3. Body weight exceeding 150 kg.
4. Inability to cooperate with the study procedures or to maintain the required position during the DTS scan.

Where it's running

  • Meir Medical Center5
    Kfar Saba, Israel
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.